{"name":"Synairgen Research Ltd.","slug":"synairgen-research-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SNG001","genericName":"SNG001","slug":"sng001","indication":"Treatment of COVID-19","status":"phase_3"}]}],"pipeline":[{"name":"SNG001","genericName":"SNG001","slug":"sng001","phase":"phase_3","mechanism":"SNG001 is an inhaled interferon beta-1a, which works by stimulating the body's immune response to fight off respiratory viruses.","indications":["Treatment of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5odnEteGJxZENfdjdzV0paRHV4N29waGc1Z2xkNVVyN0lsYnI1bi01NXV0UVZCSFdWR1ByYmo0SHJHc3pGZHlyLTVSUERnenRBclZudkphTVQxX1phcG4zZ2hZY0dXNnlwdElaTEFVek1BaHpZSUY4N2NrRQ?oc=5","date":"2026-03-20","type":"pipeline","source":"Fortune Business Insights","summary":"Inhaled Biologics Market Size, Share | Growth Forecast [2034] - Fortune Business Insights","headline":"Inhaled Biologics Market Size, Share | Growth Forecast [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNYW83TTltR0ZURmh0TjhVWVpEMUsyX1B6RnRfLVJRSHZKbjVWdWE4a1d5ejJmT2hueGFDVXpwS0FlamtteVlFbmdHSU5uTnQwNjdlY0JkQjB2eVdoOHRacUtTRktnd3c0c3lqeUtuOUdKaWxvNUIzVVhvSDc4LUV2N1NRZjJuTDVHUWkxYm1pOFFoelJyUlExUXFHemg1M3IxUnRTWjBRWHNUSVg1QTFZRldFdF9FMlU5SC1XVXJoSzZuUkJSN0didEZDY1lfNFdhUjBMczZiQkNuQ293ck9xaVFLM1U1UzB3YUVhYUF2T1U5UFNmMmZVbUVHWERqRmwwSXpfdDZwZElqSGVaaV9vRzNfQndqOHV6MHhNM0psWWM5dkxZeUxJMzEtT2R1WHFubVdNTkhUZWEzYjBwOG9idFg5MHJodzZaTTEzN3JxRUNOclhwU1Nj?oc=5","date":"2025-11-06","type":"pipeline","source":"GlobeNewswire","summary":"Global Oxygen Therapy Equipment Market is Predicted to - GlobeNewswire","headline":"Global Oxygen Therapy Equipment Market is Predicted to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOVE83cG41VGdaa2U0WnpzYUpxVDlBLUtCa05DaTlhOUVQQWtXaFRMbTlXTEFlbnNybGhiSWVOT01XZ25BN2YzRjhKdm83YVFUY3ZldjAyLVJQY1lwVXExSDl3VkNBSVY0SDI3MGxUcXpwajZOMjdoWDNkS3FLTDZWb050UC1LQXpJTjRCZ0dpZS0wQjNFcmVtN2k2enhHQldtNEZrMmItaVFrMXhQTGJBcWRoVFRDNHpYUklWOFk0UEZmeHl5MnZDUjQ5aWVDLWItQWNHb0FZZmszZFNrS2xSWGRXeXEyWGJzR0p4Z29EMUZkaUNfZlZRVG81bDVMS01yYWllakR1WmtBU3UzeHc?oc=5","date":"2025-10-21","type":"regulatory","source":"PR Newswire","summary":"Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOSWxxa2ZMUm01RFgwTkdxRVdsZWtEcW1xV0ZxT0x3UHUzY01QV19FcUc2d3NhWmV6alA0WGhlalkzZ252UVNoZ1BxcXJTVHdRYmRTQksyYXk2WWhIdDg3c3d1a3ppUThvOExxVDBzdENLXzh1M2UyQkRBMVFHMVllQ2o4YmtGNnNtNmpDM0RBbUdIMGlQcHlnNzY3YjlPMG1DUWs4cHVBbWhKMXB2cE9lcFlnRS11QWFrOXpkYWtyUEZSODJBTXNxcDZmZEFMcGJ4S24yOXVmNlpHR2k5WGRuQTg2YmNhTE0weEZaNFgyTW0?oc=5","date":"2025-09-08","type":"pipeline","source":"PR Newswire","summary":"Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxQYWdqX2dlTDJKWGdVdEV1TEpJSTJlLWg5cFJxV2pIYm9mcWl6VzVuZ1JZazlzQkhjYVQ1RFdJN2VoZFk1Y1JtOGE2Z3RoVlJBVHY2VFJQWjk5T0dDTi1jMVFISVVXVUdQZnFlRVA1UXRVQjhHdzZDMXBrNl9ESDYydGt3VUQtT2dGWXF4V0FIN0NoZm8ybEZDTm5HdzlSeFBRdzJpT0N6TjVjTUNKLXp3OExQbE52ZkZfQmtVUFBNaEdqUlZKQXRtN1RJQmxlR3RPWm45NFdsTVluSEEwaDBDdGFpSWpzZmhfWk5GNU9ETFpyTEdNdTN1SUh2WDVrNTVKbGNkSWNUZmdTNjZDb2VQUDRnTmVlMzgycHMwOXBpSHhRUjNlOUI0c3Jkdm9EbloydldRRE9yRE1Qelk?oc=5","date":"2025-05-20","type":"pipeline","source":"PR Newswire","summary":"MAC Lung Disease Market Poised for Growth Across the 7MM During the Forecast Period (2025-2034) Amid Rising Prevalence and New Therapeutic Solutions | DelveInsight - PR Newswire","headline":"MAC Lung Disease Market Poised for Growth Across the 7MM During the Forecast Period (2025-2034) Amid Rising Prevalence a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOQjBrSWRjd2RzQ1J0emZSYXVWQ25WVXBiY3JFNHdTcW9tNnptSnFrME9TTlJwTUl3cTVUSTNlODVLeW9mM2F2ZU9UQ0dHN1l4bm1iYmJlbzJOc3RKWVpuUUpFbTFhUHhFaWI4dEFCZlhRWDFjUEJyempSSkhxclc0aHlpZHJNWk9ObEhHcjdYUkpfUmVBNHNzeGt2VDdrNjNiUk5pM3RVZ3czQkkwSU9vcmdtdnQ4eS1xdjlWZldHRDAxd0U1dGdhcUR6QTgyUVJ3?oc=5","date":"2023-11-14","type":"pipeline","source":"respiratory-therapy.com","summary":"Aerogen Collaborating on COVID-19 Therapeutics - respiratory-therapy.com","headline":"Aerogen Collaborating on COVID-19 Therapeutics - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9sbjM0b1VKTEpwZXgwdTExZmgwN21rWkJPVmtLN25EbXJ5dnE0bERFVFhlVVhtZDFFMWVrS1RIbElGc1hnOVNJQVBRU2FldllOMDM5RzFQdVltUFZXTHFjQlB0R2syWEUtc25Ia0tKM2lVZw?oc=5","date":"2020-02-20","type":"pipeline","source":"pf-media.co.uk","summary":"Pharma R&D is leading the way for UK - pf-media.co.uk","headline":"Pharma R&D is leading the way for UK - pf","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}